Adherence to the medical regimen during the first two years after lung transplantation

Transplantation

Volumn 85, Issue 2, 2008, Pages 193-202

  Dew, Mary Amanda ^a,b,c   DiMartini, Andrea F ^a,c   De Vito Dabbs, Annette ^d   Zomak, Rachelle ^c   De Geest, Sabina ^e,f   Dobbels, Fabienne ^f   Myaskovsky, Larissa ^a,g   Switzer, Galen E ^a,g   Unruh, Mark ^a   Steel, Jennifer L ^a,c   Kormos, Robert L ^c   McCurry, Kenneth R ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adherence; Heart transplantation; Lung transplantation; Risk factors

Indexed keywords

ALCOHOL; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CAREGIVER; CAREGIVER SUPPORT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; EXERCISE; FEMALE; GRAFT RECIPIENT; HEALTH INSURANCE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY;

ADULT; EMOTIONS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; INCOME; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; PATIENT COMPLIANCE; SOCIAL SUPPORT; TREATMENT REFUSAL;

EID: 38549120658     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318160135f     Document Type: Article

References (71)

1. U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2006 Annual Report, Transplant Data 1996-2005. Richmond, VA: United Network for Organ Sharing; 2006. Available at www.optn.org/AR2006/default.htm. Accessed August 23, 2007.
2. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report - 2007. J Heart Lung Transplant 2007; 26: 782.
3. Eurotransplant International Foundation. Annual report 2005. Leiden, The Netherlands: Eurotransplant International Foundation; 2006.
4. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979.
5. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003. Available at www.emro.who.int/ncd/publications/adherence_rpt.pdf. Accessed November 6, 2007.
6. Avery RK. Infections after lung transplantation. Semin Respir Crit Care Medicine 2006; 27: 544.
7. Bjortuft O, Johansen B, Boe J, et al. Daily home spirometry facilitates early detection of rejection in single lung transplant recipients with emphysema. Eur Respir J 1993; 6: 705.
8. Husain AN, Siddiqui MT, Holmes EW, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999; 159: 829.
9. Knoop C, Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Medicine 2006; 27: 521.
10. McDonald JW, Keller CA, Ramos RR, Brunt EM. Mixed (neutrophilrich) interstitial pneumonitis in biopsy specimens of lung allografts: A clinicopathologic evaluation. Chest 1998; 113: 117.
11. Al-Githmi I, Batawil N, Shigemura N, et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardio-thoracic Surg 2006; 30: 846.
12. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858.
13. De Vito Dabbs A, Hoffman LA, Iacono AT, et al. Pattern and predictors of early rejection after lung transplantation. Am J Critical Care 2003; 12: 497.
14. Evon DM, Burker EJ, Sedway JA, et al. Tobacco and alcohol use in lung transplant candidates and recipients. Clin Transplant 2005; 19: 207.
15. Matthees BJ, Anantachoti P, Kreitzer MJ, et al. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung 2001; 30: 258.
16. Teichman BJ, Burker EJ, Weiner M, Egan TM. Factors associated with adherence to treatment regimens after lung transplantation. Prog Transplant 2000; 10: 113.
17. Goetzmann L, Moser KS, Vetsch E, et al. How does psychological processing relate to compliance behaviour after lung transplantation? A content analytical study. Psychol Health Medicine 2007; 12: 94.
18. Kugler C, Fischer S, Gottlieb J, et al. Symptom experience after lung transplantation: Impact on quality of life and adherence. Clin Transplant 2007; 21: 590.
19. Cupples S, Dew MA, Grady KL, et al. Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: Present status of research on psychosocial outcomes in cardiothoracic transplantation: Review and recommendations for the field. J Heart Lung Transplant 2006; 25: 716.
20. De Geest S, Dobbels F, Fluri C, et al. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005; 20: S88.
21. Department of Health and Human Services, United States Government. Annual Update of the HHS Poverty Guidelines. Federal Register 2002; 67: 6931.
22. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949: 191.
23. Grieco A, Long CJ. Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psychol 1984; 3: 129.
24. Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl; in press.
25. DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42: 200.
26. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487.
27. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996; 15: 631.
28. Dew MA, Kormos RL, Roth LH, et al. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549.
29. Simmons RG, Abress L, Anderson CR. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation 1988; 45: 415.
30. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press; 1987.
31. de Vet HCW, Terwee CB, Bouter LM. Current challenges in clinimetrics. J Clin Epidemiol 2003; 56: 1137.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." Apractical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12: 189.
33. First M, Spitzer RL, Gibbon W, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), version 2.0. New York: New York State Psychiatric Institute; 1995.
34. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972; 3: 257.
35. Derogatis LR. SCL-90R administration, scoring and procedures manual-II, 2nd ed. Towson, MD: Clinical Psychometrics Research, 1983.
36. Scheier MF, Carver CS. Effects of optimism on psychological wellbeing: Theoretical overview and empirical update. Cognitive Ther Res 1992; 16: 201.
37. Wallston KA, Wallston BS. Health locus of control scales. In: Lefcourt H, ed. Research with the locus of control construct. New York: Academic Press; 1981: 189.
38. Spanier GB. Measuring dyadic adjustment: New scales for assessing the quality of marriage and similar dyads. J Marriage Family 1976; 38: 15.
39. Pearlin LI, Schooler C. The structure of coping. J Health Social Behavior 1978; 19: 2.
40. Dew MA, Kormos RL, DiMartini AF, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics 2001; 42: 300.
41. Dew MA, Myaskovsky L, DiMartini AF, et al. Onset, timing and risk for depression and anxiety in family caregivers to heart transplant recipients. Psychol Med 2004; 34: 1065.
42. Moos RH. Evaluating correctional and community settings. New York: Wiley; 1975.
43. Cox DR, Oakes D. Analysis of survival data, 2nd edition. London: Chapman & Hall; 1984.
44. Tabachnick BG, Fidell LS. Using multivariate statistics, 5th edition. Needham Heights, MA: Pearson/Allyn & Bacon; 2007.
45. Dew MA, Dunbar-Jacob J, Switzer GE, et al. Adherence to the medical regimen in transplantation. In: JR Rodrigue, ed. Biopsychosocial perspectives on transplantation. New York: Kluwer Academic/Plenum Publishers; 2001; 93.
46. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: A review of the research. Ann Behav Medicine 1997; 19: 239.
47. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000; 70: 1240.
48. Montgomery SA, Kasper S. Side effects, dropouts from treatment and cost consequences. Int Clin Psychopharmacol. 1998; 13: S1.
49. Berlakovich GA, Langer F, Freundorfer E, et al. General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int 2000; 13: 129.
50. Liu WJ, Zaki M. Medication compliance among renal transplant patients: A Hospital Kuala Lumpur experience. Med J Malaysia 2004; 59: 649.
51. Muñoz SJ. Tobacco use by liver transplant recipients: Grappling with a smoking gun. Liver Transplant 2005; 11: 606.
52. Collins CM, Beresford TP. Smoking and heart transplantation. Curr Opin Organ Transplant 1999; 4: 155.
53. Pollard JD, Hanasono MM, Mikulec AA, et al. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110: 1257.
54. Finkelstein SM, Snyder M, Edin-Stibbe C, et al. Monitoring progress after lung transplantation from home-patient adherence. J Med Engineer Technol 1996; 20: 203.
55. Karl BC, Finkelstein SM, Robiner WN. The design of an internet-based system to maintain home monitoring adherence by lung transplant recipients. IEEE Transactions Inform Technol Biomed 2006; 10: 66.
56. Morlion B, Knoop C, Paiva M, Estenne M. Internet-based home monitoring of pulmonary function after lung transplantation. Am J Resp Crit Care Med 2002; 165: 694.
57. Burker EJ, Evon DM, Galanko J, Egan T. Health locus of control predicts survival after lung transplant. J Health Psychol 2005; 10: 695.
58. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840.
59. Goldfarb-Rumyantzev AS, Koford JK, et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol 2006; 1: 313.
60. Sanders CE, Curtis JJ, Julian BA, et al. Tapering or discontinuing cyclosporine for financial reasons - a single-center experience. Am J Kidney Dis 1993; 21: 9.
61. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: Influence of neighborhood income, education, and insurance. Liver Transplant 2004; 10: 235.
62. Chisholm M. Increasing medication access to transplant recipients. Clin Transplant 2004; 18: 39.
63. Gordon EJ, Prohaska T, Siminoff LA, et al. Needed: Tailored exercise regimens for kidney transplant recipients. Am J Kidney Dis 2005; 45: 769.
64. Dew MA, Switzer GE, DiMartini AF, et al. Psychosocial assessments and outcomes in organ transplantation. Prog Transplant 2000; 10: 239.
65. Bush BA. Psychosocial, emotional, and neuropsychologic factors influence compliance and liver transplantation outcomes. Curr Opinion Organ Transplant 2004; 9: 104.
66. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care 2007; 45: 521.
67. DiMartini A, Day N, Dew MA, et al. Alcohol use following liver transplantation: A comparison of follow-up methods. Psychosomatics 2001; 42: 55.
68. Chapman JR. Compliance: The patient, the doctor, and the medication? Transplantation 2004; 77: 782.
69. Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health outcomes of patients with heart failure: A systematic review of randomized controlled trials. BMC Cardiovasc Disord 2006; 6: 43.
70. Russell, CL. Culturally responsive interventions to enhance immunosuppressive medication adherence in older African American kidney transplant recipients. Prog Transplant 2006; 16: 187.
71. Sanders CE, Julian BA, Gaston RS, et al. Benefits of continued cyclosporin through an indigent drug program. Am J Kidney Dis 1996; 28: 572.